Literature DB >> 30819992

Capillary versus Serum b-hydroxybutyrate in Pediatric Diabetic Ketoacidosis.

Praveen M Kurup1, Ramachandran Rameshkumar2, Rajendran Soundravally3, Ponnarmeni Satheesh1.   

Abstract

OBJECTIVE: To find the strength of agreement between point-of-care and serum b-hydroxybutyrate.
METHODS: 236 paired samples (capillary b-hydroxybutyrate by a point of care device and serum b-hydroxybutyrate by colorimetric enzymatic estimation) samples were collected from 26 children aged <13 years admitted with diabetic ketoacidosis. Inborn errors of metabolism and septic shock were excluded.
RESULTS: Capillary b-hydroxybutyrate showed excellent agreement with serum â-hydroxybutyrate with mean (SD) bias of 0.027 (0.78); 95% limit of agreement -1.51, 1.56 and intraclass correlation 96.1% (95%CI 95%-97%, P<0.001). An increase in the bias noted for value above 5 mmol/L (P<0.001) (serum measurements were higher than capillary point-of-care measure-ments). Capillary â-hydroxybutyrate correlated significantly with blood pH, anion gap,bicarbonate and carbon dioxide levels on blood gas analysis (P<0.05).
CONCLUSIONS: Capillary b-hydroxybutyrate estimation is a valid method for monitoring of ketonemia in pediatric diabetic ketoacidosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30819992

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  2 in total

1.  Method comparison of beta-hydroxybutyrate point-of-care testing to serum in healthy children.

Authors:  Komalben Parmar; Maua Mosha; David A Weinstein; Rebecca Riba-Wolman
Journal:  JIMD Rep       Date:  2021-08-22

Review 2.  Application of bench studies at the bedside to improve outcomes in the management of severe diabetic ketoacidosis in children-a narrative review.

Authors:  Namita Ravikumar; Arun Bansal
Journal:  Transl Pediatr       Date:  2021-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.